Group 1: Approval and Safety Standards - The approved daily intake of allulose by the FDA is 33 grams, while the National Health Commission (NHC) of China has set it at 20 grams, reflecting stricter domestic standards [2][3] - The approval process for allulose took approximately two years for the company, involving safety evaluations by both the Ministry of Agriculture and the NHC [1][2] Group 2: Market Potential and Product Development - The future market potential for allulose is estimated to be between 150,000 to 200,000 tons over the next 3 to 5 years, particularly in beverages, baking, dairy products, and sauces [4] - The company is focusing on optimizing enzyme costs and production processes, as well as conducting extensive research on the application of allulose in various food products [2][3] Group 3: Competitive Advantages - The company holds a first-mover advantage in market access, which is crucial for future development [3] - The core competencies include a strong R&D platform for synthetic biology and a comprehensive industrial layout, particularly in the sugar raw materials sector [3] Group 4: Customer Interaction and Market Readiness - There is significant interest from downstream customers, including tea and dairy companies, indicating a readiness to purchase allulose products once approved for domestic use [2][3] - The company is prepared to offer allulose in both liquid and solid forms based on customer needs and cost assessments [4]
中粮科技(000930) - 000930中粮科技投资者关系管理信息20250711